Florida hospital executives advocate for vital policy changes to improve healthcare access and affordability. Discover key insights from their D.C. meetings.

Discover how Plenful's MFP Intelligence optimizes Medicare refunds, enhances pharmacy operations, and improves compliance across health systems for financial stability.

Discover how RxParadigm's strategic alliance enhances compliance and efficiency for community health centers through innovative 340B drug management solutions.

Discover how WSHA is shaping healthcare legislation in Washington, advocating for vital bills and addressing pressing issues like drug pricing and medical oversight.

Explore the Fifth Circuit's ruling affecting hospital payments and 340B eligibility, highlighting key regulatory compliance challenges for healthcare providers.

CMS announces changes to Medicare drug price negotiations; ongoing litigation surrounds 340B rebate model and state drug pricing laws, affecting Medicare Advantage plans and Part D reimbursement.

CMS finalizes 2026 Medicare outpatient payment rule with expanded site-neutral payments, enhanced hospital price transparency, and telehealth supervision provisions affecting hospitals and ASCs nationwide.

Explore recent US developments on federal drug price negotiation expansion to commercial plans, DEA telehealth prescribing extensions, the 340B rebate pilot launch, and ACA subsidy debates in the Senate impacting insurance and healthcare markets.

CMS releases the Calendar Year 2026 OPPS-ASC Final Rule, impacting Medicare reimbursement rates for hospital outpatient services, radiopharmaceuticals, and 340B drug pricing.

Hospitals challenge HHS's 340B pilot shifting drug discounts to a rebate system, citing financial risks and regulatory concerns.